Department of Infection Control Science, Graduate School of Medicine, Juntendo University.
Antimicrob Agents Chemother. 2013 Oct;57(10):4861-71. doi: 10.1128/AAC.00720-13. Epub 2013 Jul 22.
Three types of phenotypic expression of β-lactam resistance have been reported in methicillin-resistant Staphylococcus aureus (MRSA): heterogeneous, homogeneous, and Eagle-type resistance. Heterogeneous-to-homogeneous conversion of β-lactam resistance is postulated to be caused by a chromosomal mutation (chr*) in addition to the expression of the mecA gene. Eagle-type resistance is a unique phenotype of chr* occurring in pre-MRSA strain N315 whose mecA gene expression is strongly repressed by an intact mecI gene. We here report that certain mutations of the rpoB gene, encoding the RNA polymerase β subunit, belong to chr*. We studied homogeneous MRSA (homo-MRSA) strain N315ΔIP-H5 (abbreviated as ΔIP-H5), which was obtained from hetero-MRSA strain N315ΔIP by selection with 8 mg/liter imipenem. Whole-genome sequencing of ΔIP-H5 revealed the presence of a unique mutation in the rpoB gene, rpoB(N967I), causing the amino acid replacement of Asn by Ile at position 967 of RpoB. The effect of the rpoB(N967I) mutation was confirmed by constructing a revertant H5 rpoB(I967N) strain as well as an N315-derived mutant, N315 rpoB(N967I). H5 rpoB(I967N) regained the hetero-resistance phenotype, and the N315 rpoB(N967I) strain showed an Eagle-type phenotype similar to that of the typical Eagle-type MRSA strain N315h4. Furthermore, subsequent whole-genome sequencing revealed that N315h4 also had a missense mutation of rpoB(R644H). Introduction of the rpoB(N967I) mutation was accompanied by decreased autolysis, prolonged doubling time, and tolerance to bactericidal concentrations of methicillin. We consider that rpoB mutations are the major cause for heterogeneous-to-homogeneous phenotypic conversion of β-lactam resistance in MRSA strain N315 and its derived strains.
已报道耐甲氧西林金黄色葡萄球菌(MRSA)存在 3 种表型的β-内酰胺类药物耐药:异质性、同质性和鹰型耐药。除 mecA 基因表达外,推测β-内酰胺类药物耐药的异质性-同质性转换是由染色体突变(chr*)引起的。鹰型耐药是 pre-MRSA 菌株 N315 的独特表型,其 mecA 基因的表达受到完整 mecI 基因的强烈抑制。我们在此报告,编码 RNA 聚合酶β亚基的 rpoB 基因突变属于 chr*。我们研究了从异质性 MRSA(homo-MRSA)菌株 N315ΔIP-H5(简称ΔIP-H5)获得的同质性 MRSA (homo-MRSA)菌株 N315ΔIP,该菌株通过 8mg/L 亚胺培南的选择获得。ΔIP-H5 的全基因组测序显示 rpoB 基因存在一个独特的突变,rpoB(N967I),导致 RpoB 第 967 位的天冬酰胺被异亮氨酸取代。rpoB(N967I)突变的影响通过构建回复突变体 H5 rpoB(I967N)菌株以及源自 N315 的突变体 N315 rpoB(N967I)菌株得到证实。H5 rpoB(I967N)恢复了异质性耐药表型,而 N315 rpoB(N967I)菌株表现出类似于典型鹰型 MRSA 菌株 N315h4 的鹰型表型。此外,随后的全基因组测序显示 N315h4 还存在 rpoB(R644H)的错义突变。引入 rpoB(N967I)突变伴随着自溶减少、倍增时间延长和对杀菌浓度的甲氧西林的耐受性增加。我们认为 rpoB 突变是 MRSA 菌株 N315 及其衍生菌株中β-内酰胺类药物耐药的异质性-同质性表型转换的主要原因。